The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sexually Transmitted Diseases Testing-Global Market Insights and Sales Trends 2025
Synopsis
Sexually transmitted diseases (STDs) can be caused by infections that are passed from one person to another person through sexual contact. It can also be transmitted through nonsexual modes such as from mother to infant during pregnancy, childbirth, blood transfusions, and through shared needles.
The global Sexually Transmitted Diseases Testing market size is expected to reach US$ 104270 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Sexually Transmitted Diseases Testing in various end use industries. The expanding demands from the Clinics, Hospitals and Other, are propelling Sexually Transmitted Diseases Testing market. Chlamydia Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Gonorrhea Testing segment is estimated at % CAGR for the next seven-year period.
The Americas will be the major revenue contributor to the sexually transmitted diseases testing market owing to the advanced healthcare infrastructure in this region. Also, the increasing awareness about STD testing and the initiatives taken by governments to promote various tests will drive the growth of the STD screening market in this region.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sexually Transmitted Diseases Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sexually Transmitted Diseases Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sexually Transmitted Diseases Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sexually Transmitted Diseases Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sexually Transmitted Diseases Testing covered in this report include BioMerieux, F. Hoffmann La Roche, BD, Abbott, Bio-Rad Laboratories, Abbott and Qiagen, etc.
The global Sexually Transmitted Diseases Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BioMerieux
F. Hoffmann La Roche
BD
Abbott
Bio-Rad Laboratories
Abbott
Qiagen
Global Sexually Transmitted Diseases Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sexually Transmitted Diseases Testing market, Segment by Type:
Chlamydia Testing
Gonorrhea Testing
Syphilis Testing
HIV Testing
HSV Testing
HPV Testing
Chancroid Testing
Other
Global Sexually Transmitted Diseases Testing market, by Application
Clinics
Hospitals
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Sexually Transmitted Diseases Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Sexually transmitted diseases (STDs) can be caused by infections that are passed from one person to another person through sexual contact. It can also be transmitted through nonsexual modes such as from mother to infant during pregnancy, childbirth, blood transfusions, and through shared needles.
The global Sexually Transmitted Diseases Testing market size is expected to reach US$ 104270 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029. The market is mainly driven by the significant applications of Sexually Transmitted Diseases Testing in various end use industries. The expanding demands from the Clinics, Hospitals and Other, are propelling Sexually Transmitted Diseases Testing market. Chlamydia Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Gonorrhea Testing segment is estimated at % CAGR for the next seven-year period.
The Americas will be the major revenue contributor to the sexually transmitted diseases testing market owing to the advanced healthcare infrastructure in this region. Also, the increasing awareness about STD testing and the initiatives taken by governments to promote various tests will drive the growth of the STD screening market in this region.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sexually Transmitted Diseases Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sexually Transmitted Diseases Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sexually Transmitted Diseases Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sexually Transmitted Diseases Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sexually Transmitted Diseases Testing covered in this report include BioMerieux, F. Hoffmann La Roche, BD, Abbott, Bio-Rad Laboratories, Abbott and Qiagen, etc.
The global Sexually Transmitted Diseases Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BioMerieux
F. Hoffmann La Roche
BD
Abbott
Bio-Rad Laboratories
Abbott
Qiagen
Global Sexually Transmitted Diseases Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sexually Transmitted Diseases Testing market, Segment by Type:
Chlamydia Testing
Gonorrhea Testing
Syphilis Testing
HIV Testing
HSV Testing
HPV Testing
Chancroid Testing
Other
Global Sexually Transmitted Diseases Testing market, by Application
Clinics
Hospitals
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Sexually Transmitted Diseases Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Sexually Transmitted Diseases Testing
1.1 Sexually Transmitted Diseases Testing Market Overview
1.1.1 Sexually Transmitted Diseases Testing Product Scope
1.1.2 Sexually Transmitted Diseases Testing Market Status and Outlook
1.2 Global Sexually Transmitted Diseases Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Sexually Transmitted Diseases Testing Market Size by Region (2018-2029)
1.4 Global Sexually Transmitted Diseases Testing Historic Market Size by Region (2018-2023)
1.5 Global Sexually Transmitted Diseases Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Sexually Transmitted Diseases Testing Market Size (2018-2029)
1.6.1 North America Sexually Transmitted Diseases Testing Market Size (2018-2029)
1.6.2 Europe Sexually Transmitted Diseases Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Sexually Transmitted Diseases Testing Market Size (2018-2029)
1.6.4 Latin America Sexually Transmitted Diseases Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Sexually Transmitted Diseases Testing Market Size (2018-2029)
2 Sexually Transmitted Diseases Testing Market by Type
2.1 Introduction
2.1.1 Chlamydia Testing
2.1.2 Gonorrhea Testing
2.1.3 Syphilis Testing
2.1.4 HIV Testing
2.1.5 HSV Testing
2.1.6 HPV Testing
2.1.7 Chancroid Testing
2.1.8 Other
2.2 Global Sexually Transmitted Diseases Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Sexually Transmitted Diseases Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Sexually Transmitted Diseases Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Sexually Transmitted Diseases Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Sexually Transmitted Diseases Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Sexually Transmitted Diseases Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Sexually Transmitted Diseases Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Sexually Transmitted Diseases Testing Revenue Breakdown by Type (2018-2029)
3 Sexually Transmitted Diseases Testing Market Overview by Application
3.1 Introduction
3.1.1 Clinics
3.1.2 Hospitals
3.1.3 Other
3.2 Global Sexually Transmitted Diseases Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Sexually Transmitted Diseases Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Sexually Transmitted Diseases Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Sexually Transmitted Diseases Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Sexually Transmitted Diseases Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Sexually Transmitted Diseases Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Sexually Transmitted Diseases Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Sexually Transmitted Diseases Testing Revenue Breakdown by Application (2018-2029)
4 Sexually Transmitted Diseases Testing Competition Analysis by Players
4.1 Global Sexually Transmitted Diseases Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases Testing as of 2022)
4.3 Date of Key Players Enter into Sexually Transmitted Diseases Testing Market
4.4 Global Top Players Sexually Transmitted Diseases Testing Headquarters and Area Served
4.5 Key Players Sexually Transmitted Diseases Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Sexually Transmitted Diseases Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BioMerieux
5.1.1 BioMerieux Profile
5.1.2 BioMerieux Main Business
5.1.3 BioMerieux Sexually Transmitted Diseases Testing Products, Services and Solutions
5.1.4 BioMerieux Sexually Transmitted Diseases Testing Revenue (US$ Million) & (2018-2023)
5.1.5 BioMerieux Recent Developments
5.2 F. Hoffmann La Roche
5.2.1 F. Hoffmann La Roche Profile
5.2.2 F. Hoffmann La Roche Main Business
5.2.3 F. Hoffmann La Roche Sexually Transmitted Diseases Testing Products, Services and Solutions
5.2.4 F. Hoffmann La Roche Sexually Transmitted Diseases Testing Revenue (US$ Million) & (2018-2023)
5.2.5 F. Hoffmann La Roche Recent Developments
5.3 BD
5.3.1 BD Profile
5.3.2 BD Main Business
5.3.3 BD Sexually Transmitted Diseases Testing Products, Services and Solutions
5.3.4 BD Sexually Transmitted Diseases Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Recent Developments
5.4 Abbott
5.4.1 Abbott Profile
5.4.2 Abbott Main Business
5.4.3 Abbott Sexually Transmitted Diseases Testing Products, Services and Solutions
5.4.4 Abbott Sexually Transmitted Diseases Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Recent Developments
5.5 Bio-Rad Laboratories
5.5.1 Bio-Rad Laboratories Profile
5.5.2 Bio-Rad Laboratories Main Business
5.5.3 Bio-Rad Laboratories Sexually Transmitted Diseases Testing Products, Services and Solutions
5.5.4 Bio-Rad Laboratories Sexually Transmitted Diseases Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Bio-Rad Laboratories Recent Developments
5.6 Abbott
5.6.1 Abbott Profile
5.6.2 Abbott Main Business
5.6.3 Abbott Sexually Transmitted Diseases Testing Products, Services and Solutions
5.6.4 Abbott Sexually Transmitted Diseases Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Abbott Recent Developments
5.7 Qiagen
5.7.1 Qiagen Profile
5.7.2 Qiagen Main Business
5.7.3 Qiagen Sexually Transmitted Diseases Testing Products, Services and Solutions
5.7.4 Qiagen Sexually Transmitted Diseases Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Qiagen Recent Developments
6 North America
6.1 North America Sexually Transmitted Diseases Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Sexually Transmitted Diseases Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Sexually Transmitted Diseases Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Sexually Transmitted Diseases Testing Market Dynamics
11.1 Sexually Transmitted Diseases Testing Industry Trends
11.2 Sexually Transmitted Diseases Testing Market Drivers
11.3 Sexually Transmitted Diseases Testing Market Challenges
11.4 Sexually Transmitted Diseases Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
